Grace Therapeutics (GRCE) Stock Chart & Stock Price History $3.03 +0.01 (+0.33%) As of 10/3/2025 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Grace Therapeutics Stock Price Performance The Grace Therapeutics (GRCE) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 18.98%. In the past month, the stock has decreased 0.98%, reflecting recent market activity. As of the latest close, Grace Therapeutics traded at $3.03 with a market cap of $41.91 million and volume of 27,320 shares. Receive GRCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+2.02%1 Month Performance-0.98%3 Month Performance-3.19%Year-To-Date Performance-18.98% GRCE Stock Chart for Saturday, October, 4, 2025 GRCE Chart by TradingView Grace Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025$3.02$3.03+0.33%$3.06$3.0127,320 shs$41.91 million10/02/2025$3.07$3.02-1.63%$3.05$2.9855,455 shs$41.77 million10/01/2025$2.98$3.07+3.02%$3.09$2.9883,394 shs$42.46 million09/30/2025$2.97$2.98+0.34%$3.01$2.9147,804 shs$41.21 million09/29/2025$3.09$2.97-3.88%$3.10$2.96102,844 shs$41.08 million09/26/2025$3.08$3.09+0.32%$3.11$3.0429,097 shs$42.74 million09/25/2025$3.10$3.08-0.65%$3.12$3.0185,086 shs$42.59 million09/24/2025$3.11$3.10-0.32%$3.14$3.0771,977 shs$42.87 million09/23/2025$3.11$3.11$3.11$3.0661,099 shs$43.01 million09/22/2025$3.10$3.11+0.32%$3.14$3.0846,662 shs$43.01 million Get the Latest News and Ratings for GRCE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025$3.12$3.10-0.64%$3.13$3.0840,710 shs$42.87 million09/18/2025$3.06$3.12+1.96%$3.18$3.06167,252 shs$43.15 million09/17/2025$3.09$3.06-0.97%$3.14$3.0460,819 shs$42.32 million09/16/2025$3.07$3.09+0.65%$3.15$3.0736,619 shs$42.73 million09/15/2025$3.15$3.07-2.54%$3.14$3.0564,568 shs$42.46 million09/12/2025$3.22$3.15-2.17%$3.22$3.0789,550 shs$43.56 million09/11/2025$3.26$3.22-1.23%$3.30$3.18185,083 shs$44.53 million09/10/2025$3.26$3.26$3.28$3.2445,552 shs$45.08 million09/09/2025$3.24$3.26+0.62%$3.30$3.2294,550 shs$45.09 million09/08/2025$3.20$3.24+1.25%$3.34$3.2284,724 shs$44.81 million09/05/2025$3.06$3.20+4.58%$3.30$3.06257,036 shs$44.26 million09/04/2025$2.97$3.06+3.03%$3.13$2.9579,451 shs$42.32 million09/03/2025$2.99$2.97-0.67%$2.99$2.9328,566 shs$41.08 million Related Companies Neoleukin Therapeutics Stock Price Chart Genelux Stock Price Chart Citius Oncology Stock Price Chart Actuate Therapeutics Stock Price Chart Corbus Pharmaceuticals Stock Price Chart Eledon Pharmaceuticals Stock Price Chart Theratechnologies Stock Price Chart Tevogen Bio Stock Price Chart Cybin Stock Price Chart Cassava Sciences Stock Price Chart Receive GRCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GRCE) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredLost Decade warning – do this nowWith the Magnificent 7 trading at bubble-like valuations, another “Lost Decade” could be looming — but Porter ...Porter & Company | SponsoredThe next biggest bull run in over 50 yearsGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
